Marlo Danielle 💎🍿🙌🏻🦍

#𝑨𝑪𝑻𝑰𝑽𝑰𝑺𝑻 ! ℙ𝕣𝕠𝕗��𝕤𝕤𝕚𝕠𝕟𝕒𝕝 Candid ℙ𝕙𝕠𝕥𝕠𝕘𝕣𝕒𝕡𝕙𝕖𝕣. Owner & Creator of 𝓟𝓮𝓻𝓯𝓮𝓬𝓽𝓵𝔂Unposed📸!#AnimalRights🐾 IG: MarloDanielle1919

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

#ChristinaAguilera You Are #Beautiful😍
#BestVoice 🎤 && an #AmazingSoul 😇
@ChristinaAguilera 🤩

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@Benson_Tik @russellbrunson 💯

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@PriyadarshniBi3 @russellbrunson Definitely!!

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@RiseOpenEyes @X Omg I just got mine back!! Almost 2 weeks of going back & fourth w automated emails w X!
They changed my password, my email, and 2FA 😭!!! Even started posting crypto stuff, & now completely locked out of DM’s and they put a code on it and I can’t get in there 😩

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@universevibe_ 💯

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@MolecularLab_ 🤩

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@MolecularLab_ Yum

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@rizvispeaking @internetarchiva 🔥😍

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@LightOverLies @providentialy 🎯

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@ENTMD4Me @CollinRugg I agree!!

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@Masculincreed 🙌🏻💯!!

I’d just make sure it’s 100% sodium bicarbonate, no aluminum, no fillers or additives

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@DavidWolfe 💯 Yess!!
🌱🪻🫚🪴

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@dezzie_rezzie @grok Your picture doesn’t have that demon thing above his head, like his had.
Idk if that changes the prompt at all?

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@greg16676935420 @tkanthh 😂 yeah duh, cape mode.
Wow, Trump’s out here doing full~on miracle healing with the glowing hand upgrade. Greg, you forgot the demon floating right above his head in the clouds though - that’s the real plot twist!! 👹👿😳😵

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@grok @Myellahub @te_nago @HerbalistChief This is awesome, I’m gonna try to grow it!!
🌱🪴

[Nicolas Hulscher, MPH @NicHulscher]

🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression

After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️

We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

@twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@moore6072 @DawnsMission @grok Omg 😱 soo disgusting!! They are completely poisoning us!!!

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@Thebestfigen 🥹🥰🫶🏻

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@_Healthyorg Health

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@piersmorgan @jayborger14 @realDonaldTrump 😳😵

[Marlo Danielle 💎🍿🙌🏻🦍 @MarloDanielle]

@_salmarose_ Energy and character are contagious. Stay around people who move with integrity—because you don’t become what you say you are… you become what you’re around. Rise to the life you want, don’t fall into the habits your environment creates. Definitely choose your circle wisely…